ClinicalTrials.gg

Eli Lilly and Company: Carcinoma, Hepatocellular trials

The registry lists 13 Carcinoma, Hepatocellular studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 7Phase 2 7Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.